Spontaneous adverse drug reaction reporting in rural districts of Mozambique

Drug Safety

Volumn 31, Issue 10, 2008, Pages 867-876

  Sevene, Esperança ^a   Mariano, Alda ^a   Mehta, Ushma ^b   MacHai, Maria ^c   Dodoo, Alexander ^d   Vilardell, David ^e   Patel, Sam ^a   Barnes, Karen ^b   Carné, Xavier ^e  

^a EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MINISTRY OF HEALTH   (Mozambique)

^d UNIVERSITY OF GHANA   (Ghana)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Adverse reaction monitoring; Pharmacovigilance

Indexed keywords

ACETYLSALICYLIC ACID; AMODIAQUINE; AMOXICILLIN; ARTESUNATE; CHLOROQUINE; COTRIMOXAZOLE; ERYTHROMYCIN; FANSIDAR; FERROUS SULFATE PLUS FOLIC ACID; NALIDIXIC ACID; PARACETAMOL; PENICILLIN V; PROCAINE PENICILLIN; PYRAZINAMIDE; QUININE;

ABDOMINAL DISCOMFORT; AFRICA; ARTICLE; CONVULSION; DEVELOPING COUNTRY; DIZZINESS; DRUG SURVEILLANCE PROGRAM; ERYTHEMA; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; INSOMNIA; MACULOPAPULAR RASH; MOZAMBIQUE; NAUSEA; PRIORITY JOURNAL; PRURITUS; QUALITY CONTROL; RESTLESSNESS; RURAL AREA; TELECOMMUNICATION; TRAINING; TREMOR; URTICARIA; VESICULAR RASH; VISUAL DISORDER; WEAKNESS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIMALARIALS; COMMUNITY PHARMACY SERVICES; HUMANS; MOZAMBIQUE; PUBLIC HEALTH; RURAL POPULATION; SAFETY MANAGEMENT; TELECOMMUNICATIONS; TIME FACTORS;

EID: 50649103021     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831100-00005     Document Type: Article

References (21)

1. Lindquist M. Seeing and observing in international pharmacovigilance. Uppsala: Uppsala Monitoring Centre, 2000
2. Meyboom RH, Egberts AD, Edwards IR, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16 (6): 355-65
3. Laporte JR. Princípios basicos de investigação clinica. Madrid: Zeneca Farma, 1993
4. Edwards IR. The accelerating need for pharmacovigilance. J R Col Physicians Lond 2000; 34 (1): 48-51
5. Edwards IR, Lindquist M, Meyboom R, et al. Pharmacovigilance in focus in drug safety. Uppsala Monitoring Centre, 2000
6. Uppsala Monitoring Centre. WHO programme for international drug monitoring [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?id= 13140 [Accessed 2008 Aug 5]
7. Haas DW, Ribaudo JR, Kim RB, et al. Pharmacogenetics of efavirenz and central nervous system side effects: an adult AIDS clinical trial group study. AIDS 2004; 18: 2391-400
8. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Safety 2004; 27 (1): 25-61
9. Edwards IR. Safety monitoring of new anti-malarials in immediate post-marketing phase. Med Trop (Mars) 1998; 58 (3): 93-6
10. Simooya O. Introducing pharmacovigilance in public health programmes. Drug Safety 2005; 28 (4): 277-86
11. Programa Nacional de Controlo da Malaria. Normas de tratamento da malaria. Maputo: MISAU, 2001
12. Programa Nacional de Controlo de ITS/HIV/SIDA. Plano estratégico nacional de combate às ITS/HIV/SIDA do MISAU 2004-2008. Maputo: MISAU, 2004
13. Instituto Nacional de statistica. Dados demograficos [online]. Available from URL: http://www.ine.gov.mz [Accessed 2005 Sep 21]
14. Sharp BL, Kleinschmidt I, Streat E, et al. Seven years of regional malaria control collaboration: Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 2007; 76 (1): 42-7
15. World Health Organization. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala: Uppsala Monitoring Centre, 2000
16. The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP): the first ten years. "Defining the problem and developing solutions". Dec 2005 [online]. Available from URL: http://www.nccmerp.org [Accessed 2008 Aug 05]
17. Moore N. The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Safety 2001; 24 (1): 1-7
18. Avarez-Requejo A, Carvajal A, Begaud B, et al. Under-reporting of adverse drug reactions: estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998; 54 (6): 483-8
19. Bégaud B, Martin K, Haramburu F, et al. Rates of spontaneous reporting of adverse drug reactions in France. JAMA 2002; 288: 1588
20. Figueiras A, Caama F, Gestal J. Metodología de los estudios de utilización de medicamentos en atención primaria. Gac Sanit 2000; 14 Suppl. 3: 7-19
21. Alvarez Luna F. Pharmacoepidemiology. Drug utilization studies. Part I. Concept and methodology. Seguim Farmacoter 2004; 2 (3): 129-36